Table 3 Target organ damage in Diabetics

Vascular

Carotid IMT men average (mm)

0.76 ± 0.12

0.76 ± 0.10

0.00

-1

to

1

0.82

Carotid IMT men average ≥ 90 mm, n (%)

17 (25.00)

15 (22.10)

-2.90

-4.7

to

1.2

0.63

Carotid IMT maximum average (mm)

0.94 ± 0.14

0.94 ± 0.13

0.00

-0.01

to

0.01

0.74

Carotid IMT maximum average ≥ 90 mm, n (%)

46 (67.60)

42 (61.80)

-5.80

-11

to

21

0.39

Plaques, n (%)

15 (22.10)

15 (22.10)

10

-14

to

14

1.00

ABI

1.10 ± 0.13

1.17 ± 0.08

0.07

0.04

to

0.11

< 0.001

TOD ABI, n (%)

8 (11.80)

2 (3.10)

-8.70

-17

to

10

0.03

PWV, (m/s)

9.59 ± 2.32

9.78 ± 2.49

0.19

-0.26

to

0.77

0.33

PWV ≥ 12 m/s, n (%)

10 (15.20)

11 (17.50)

2

-10

to

14

0.63

TOD Vascular, n (%)

25 (37.90)

23 (36.50)

-14

-18

to

-10

0.75

Renal

GFR CKD-EPI (mL/min/1.73 m2)

87.95 ± 13.06

88.64 ± 15.35

0.69

-2.09

to

3.32

0.65

TOD GFR CKD-EPI ≤ 60 mL/min/1.73 m2, n(/%)

1 (1.50)

3 (4.70)

3

-3

to

15

0.50

Albumin/creatinine (mg/g)

36.09 ± 82.81

34.88 ± 75.98

-1.21

-20.80

to

15.05

0.75

TOD Albumin/creatinine (mg/g), n (%)

11 (16.20)

9 (14.50)

-1.70

-15

to

9

0.06

TOD Renal n (%)

13 (20.00)

12 (19.40)

-0.60

-0.74

to

-0.50

0.63

Heart

Cornell VDP (mmms)

1648.29 ± 654.68

1584.79 ± 522.69

-29.91

-118.71

to

58.88

0.50

TOD Cornell VDP (mmms) patologico, n(%)

7 (10.30)

5 (7.80)

-2.50

-12

to

7

0.25

TOD global, n (%)

34 (51.50)

32 (50.80)

-0.7

-1.9

to

1.5

0.75